Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

NCT06664138 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Schizophenia Disorder
Major Depression Disorders
Schizoaffective Disorder
Bipolar

Interventions

DRUG: Remimazolam
DRUG: Etomidate

Sponsor

Yeongseok Yun